Bioequivalence Study of EMPAGLIFLOZIN (25 mg Tablets) vs. JARDIANCE® (25 mg Tablets), in Healthy Research Subjects, Under Fasting Conditions
Clinical trial NCT07479108 · COMPLETED
Trial details
- NCT number
- NCT07479108
- Sponsor
- ADIUM
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-29
- Primary completion
- 2024-12-11
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.